Browse by:
MetroWest/495

In human trial, Sunovion depression drug shows promise

A drug that treats major depressive episodes associated with bipolar depression improved symptoms in a statistically significant way in a human clinical study, according to its developer, Sunovion...

Single family home sales up 58% in Worcester

Single family home sales in the city of Worcester more than doubled in April, as sales statewide fell slightly but continued to outpace last year’s growth.

Biostage failed to meet NASDAQ requirements

Laura Finaldi |

Biostage will be delisted from the NASDAQ stock market if it loses an upcoming appeal, after the company failed to raise its bid price to $1 within a given 180-day period.

UMass Memorial, Harrington to join behavioral health forces

Laura Finaldi |

Responding to concerns from the state about access to inpatient psychiatric care in Central Massachusetts, UMass Memorial Health Care announced a formal partnership with Harrington HealthCare in...

Brazilian market drive Acton drug tester revenues

Psychemedics, an Acton drug-testing company, saw revenue jump by more than 50 percent in the first quarter, driving profits to $1.5 million.

New stop opening Monday on Framingham/Worcester line

Grant Welker |

A new commuter rail stop will open Monday on the Framingham/Worcester line, meaning many morning trains heading into Boston will be leaving at slightly different times.

Despite soaring revenues, Virtusa profits drop 73%

Virtusa Corp.’s GAAP net income fell by $32.9 million for the entire 2017 fiscal year, as the company increased its revenue by 43 percent.

Two new Patrick dealerships open in Worcester

The Patrick Family has purchased the former Gallo Mazda and Volvo dealerships in Worcester.

Liberty Mutual cutting 44 jobs in Hopkinton

Laura Finaldi |

Liberty Mutual is discontinuing its Hopkinton peer-reviewed research efforts and will lay off up to 44 employees effective June 6.

TJX profit grew 5% in first quarter

Shares were down 4 percent Tuesday morning after the TJX Companies, Inc. reported steady sales of $7.8 billion in its first quarter and net income growth of just over 5 percent.

ADVERTISEMENTS
Copyright 2017 New England Business Media